Sunshine Act Meeting, 38217 [2016-14045]

Download as PDF 38217 Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices We will summarize written responses to this notice and address them in our submission for OMB approval. As a result of your comments, we will make any necessary adjustments to the burden in our submission to OMB. Public Comment Procedures: Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. BSEE Information Collection Clearance Officer: Nicole Mason (703) 787–1607. Dated: June 3, 2016. Robert W. Middleton, Deputy Chief, Office of Offshore Regulatory Programs. [FR Doc. 2016–13862 Filed 6–10–16; 8:45 am] BILLING CODE 4310–VH–P INTERNATIONAL TRADE COMMISSION [USITC SE–16–019] Sunshine Act Meeting United States International Trade Commission. TIME AND DATE: June 16, 2016 at 11:00 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote in Inv. No. 731–TA–1071 (Second Review) (Alloy Magnesium from China). The Commission is currently scheduled to complete and file its determination and views of the Commission on June 30, 2016. AGENCY HOLDING THE MEETING: 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. DEPARTMENT OF JUSTICE By order of the Commission. Issued: June 8, 2016. William R. Bishop, Supervisory Hearings and Information Officer. Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc. [FR Doc. 2016–14045 Filed 6–9–16; 4:15 pm] Drug Enforcement Administration [Docket No. DEA–392] ACTION: Notice of application. [USITC SE–16–020] Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before August 12, 2016. Sunshine Act Meeting ADDRESSES: BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION United States International Trade Commission. TIME AND DATE: June 22, 2016 at 11:00 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote in Inv. Nos. 701–TA–541 and 731–TA–1284 and 1286 (Final) (ColdRolled Steel Flat Products from China and Japan). The Commission is currently scheduled to complete and file its determinations and views of the Commission on July 5, 2016. 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. AGENCY HOLDING THE MEETING: By order of the Commission. Issued: June 8, 2016. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2016–14044 Filed 6–9–16; 4:15 pm] BILLING CODE 7020–02–P DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on February 1, 2016, Sigma Aldrich Research Biochemicals, Inc., 1–3 Strathmore Road, Natick, Massachusetts 01760–2447 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: srobinson on DSK5SPTVN1PROD with NOTICES Controlled substance Schedule Cathinone (1235) ......................................................................................................................................................................................... Methcathinone (1237) .................................................................................................................................................................................. Mephedrone (4-Methyl-N-methylcathinone) (1248) .................................................................................................................................... Aminorex (1585) .......................................................................................................................................................................................... Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... Tetrahydrocannabinols (7370) ..................................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1 I I I I I I I I I I I I

Agencies

[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14045]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-16-019]


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: United States International Trade 
Commission.

TIME AND DATE: June 16, 2016 at 11:00 a.m.

PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: 
    1. Agendas for future meetings: None.
    2. Minutes.
    3. Ratification List.
    4. Vote in Inv. No. 731-TA-1071 (Second Review) (Alloy Magnesium 
from China). The Commission is currently scheduled to complete and file 
its determination and views of the Commission on June 30, 2016.
    5. Outstanding action jackets: None.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    By order of the Commission.

    Issued: June 8, 2016.
William R. Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2016-14045 Filed 6-9-16; 4:15 pm]
 BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.